Community Schedule

Enter at least 4 characters

1 results showing for: 'emtricitabine with tenofovir disoproxil'

Emtricitabine with tenofovir disoproxil    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 103.
- Subsidy by endorsement ; can be waived by Special Authority SA1994
  • Tab 200 mg with tenofovir disoproxil 245 mg (300.6 mg as a succinate)
    • Brand Fully subsidised brand. Teva
    • Pharmacode2560488
    • Subsidy $61.15
    • Measure / Qty per 30
SA1994 - Emtricitabine with tenofovir disoproxil

Endorsement for treatment of HIV: Prescription is deemed to be endorsed if emtricitabine with tenofovir disoproxil is co-prescribed with another antiretroviral subsidised under Special Authority SA1651 and the prescription is annotated accordingly by the Pharmacist or endorsed by the prescriber.

Note:

Emtricitabine with tenofovir disoproxil prescribed under endorsement for the treatment of HIV is included in the count of up to 4 subsidised antiretrovirals, and counts as two antiretroviral medications, for the purposes of Special Authority SA1651, page 1

There is an approval process to become a named specialist to prescribe antiretroviral therapy in New Zealand. Further information is available on the Pharmac website.

For eye preparations refer to Eye Preparations, Anti-Infective Preparations, page 241

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply